Dr. Rachel B. Salit

Claim this profile

Fred Hutch/University of Washington Cancer Consortium

Studies Myelofibrosis
Studies Primary Myelofibrosis
4 reported clinical trials
10 drugs studied

Area of expertise

1Myelofibrosis
Rachel B. Salit has run 3 trials for Myelofibrosis. Some of their research focus areas include:
HLA positive
RB1 positive
RB1 negative
2Primary Myelofibrosis
Rachel B. Salit has run 3 trials for Primary Myelofibrosis. Some of their research focus areas include:
HLA positive
RB1 positive
RB1 negative

Affiliated Hospitals

Image of trial facility.
Fred Hutch/University Of Washington Cancer Consortium

Clinical Trials Rachel B. Salit is currently running

More about Rachel B. Salit

Clinical Trial Related11 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Rachel B. Salit has experience with
  • Ruxolitinib
  • Cyclophosphamide
  • Fludarabine
  • Tacrolimus
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • JAK Inhibitor

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Rachel B. Salit specialize in?
Is Rachel B. Salit currently recruiting for clinical trials?
Are there any treatments that Rachel B. Salit has studied deeply?
What is the best way to schedule an appointment with Rachel B. Salit?
What is the office address of Rachel B. Salit?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security